Wells Fargo’s Lunai Bioworks Inc. Common Stock RENB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $701 | Sell |
2,425
-56,891
| -96% | -$16.4K | ﹤0.01% | 5881 |
|
2025
Q1 | $32.2K | Buy |
59,316
+215
| +0.4% | +$117 | ﹤0.01% | 5088 |
|
2024
Q4 | $49.4K | Buy |
59,101
+40,912
| +225% | +$34.2K | ﹤0.01% | 4998 |
|
2024
Q3 | $8.79K | Buy |
18,189
+450
| +3% | +$217 | ﹤0.01% | 5416 |
|
2024
Q2 | $31K | Buy |
17,739
+17,445
| +5,934% | +$30.5K | ﹤0.01% | 5087 |
|
2024
Q1 | $779 | Buy |
294
+7
| +2% | +$19 | ﹤0.01% | 5814 |
|
2023
Q4 | $910 | Buy |
287
+73
| +34% | +$231 | ﹤0.01% | 5805 |
|
2023
Q3 | $956 | Sell |
214
-273
| -56% | -$1.22K | ﹤0.01% | 5839 |
|
2023
Q2 | $276 | Sell |
487
-2,986
| -86% | -$1.69K | ﹤0.01% | 6302 |
|
2023
Q1 | $3.18K | Buy |
+3,473
| New | +$3.18K | ﹤0.01% | 5831 |
|
2022
Q4 | – | Sell |
-12
| Closed | – | – | 7321 |
|
2022
Q3 | $0 | Sell |
12
-208
| -95% | – | ﹤0.01% | 6892 |
|
2022
Q2 | $0 | Buy |
220
+126
| +134% | – | ﹤0.01% | 7036 |
|
2022
Q1 | $1K | Buy |
94
+1
| +1% | +$11 | ﹤0.01% | 6494 |
|
2021
Q4 | $1K | Buy |
93
+1
| +1% | +$11 | ﹤0.01% | 6497 |
|
2021
Q3 | $1K | Sell |
92
-3
| -3% | -$33 | ﹤0.01% | 6440 |
|
2021
Q2 | $0 | Sell |
95
-4,698
| -98% | – | ﹤0.01% | 6923 |
|
2021
Q1 | $17K | Sell |
4,793
-17,357
| -78% | -$61.6K | ﹤0.01% | 5836 |
|
2020
Q4 | $65K | Sell |
22,150
-17,193
| -44% | -$50.5K | ﹤0.01% | 5323 |
|
2020
Q3 | $141K | Sell |
39,343
-2,490
| -6% | -$8.92K | ﹤0.01% | 4939 |
|
2020
Q2 | $176K | Buy |
41,833
+9,165
| +28% | +$38.6K | ﹤0.01% | 4801 |
|
2020
Q1 | $98K | Buy |
32,668
+12,439
| +61% | +$37.3K | ﹤0.01% | 4877 |
|
2019
Q4 | $101K | Buy |
20,229
+1,485
| +8% | +$7.41K | ﹤0.01% | 5084 |
|
2019
Q3 | $103K | Buy |
18,744
+2,741
| +17% | +$15.1K | ﹤0.01% | 5078 |
|
2019
Q2 | $72K | Buy |
+16,003
| New | +$72K | ﹤0.01% | 5175 |
|